Floatz logo

Cyclophosphamide

Burkitt Leukemia

Fred Hutchinson Cancer CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Burkitt Leukemia cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
M.D. Anderson Cancer Center
Phase 2B
Inno-206
M.D. Anderson Cancer Center
Phase 2B
DEXAMETHASONE
M.D. Anderson Cancer Center
Phase 2B
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2B
VINCRISTINE SULFATE
M.D. Anderson Cancer Center
Phase 2B

View all 11 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →